Search results: Sage Journals

Restricted accessResearch articleFirst published 2019

Analysis of FDA Warning Letters Issued to Indian Pharmaceutical and Medical Device Companies: A Retrospective Study

Shray Bablani, Manthan D. Janodia

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published July, 2009

Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations

Khalid M. Kamal, Shane P. Desselle, Pallavi Rane [...]

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published March, 2022

Review of form 483s and warning letters to pharmaceutical manufacturers issued by USFDA

Chandan Saini, Ashish Miglani, Pankaj Musyuni [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published 2026

Enveloping the research evidence: How can policing deliver effective warning letters in a roads policing context?

Leanne Savigar-Shaw, Helen Wells

Criminology & Criminal Justice

Restricted accessResearch articleFirst published June, 2018

The use of psychologically-informed warning letters in probation for high-risk clients with personality difficulties

David Harvey, Wendy Sefton

Probation Journal

Restricted accessResearch articleFirst published July, 2022

Words of Warning: A Randomized Study of the Impact of Assorted Warning Letters on Academic Probation Students

Brian G. Moss, Ben Kelcey

Community College Review

Restricted accessResearch articleFirst published May, 2016

Trend Analysis of FDA Warning Letters Issued to Medical Products About Violations to Current Good Manufacturing Practices (CGMP) Between 2007 and 2014

Liqing Wang, Hang Zheng, Xiaohong Ren [...]

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published December, 2021

Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019

Kimberly G. Wagoner, Allison J. Lazard, E. Alfonso Romero-Sandoval [...]

Cannabis & Cannabinoid Research

Restricted accessOtherFirst published May, 2007

Prescription Drug Advertising and Promotion: Learnings from Recent Food and Drug Administration Warning Letters

Eric B. Benson, Sherman N. Alfors

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2018

Research Misconduct in FDA-Regulated Clinical Trials

Craig A. Garmendia, Neera Bhansali, Purnima Madhivanan

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published 2019

Analysis of FDA Warning Letters Issued to Indian Pharmaceutical and Medical Device Companies: A Retrospective Study

Shray Bablani, Manthan D. Janodia

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published July, 2009

Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations

Khalid M. Kamal, Shane P. Desselle, Pallavi Rane [...]

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published March, 2022

Review of form 483s and warning letters to pharmaceutical manufacturers issued by USFDA

Chandan Saini, Ashish Miglani, Pankaj Musyuni [...]

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published 2026

Enveloping the research evidence: How can policing deliver effective warning letters in a roads policing context?

Leanne Savigar-Shaw, Helen Wells

Criminology & Criminal Justice

Restricted accessResearch articleFirst published June, 2018

The use of psychologically-informed warning letters in probation for high-risk clients with personality difficulties

David Harvey, Wendy Sefton

Probation Journal

Restricted accessResearch articleFirst published July, 2022

Words of Warning: A Randomized Study of the Impact of Assorted Warning Letters on Academic Probation Students

Brian G. Moss, Ben Kelcey

Community College Review

Restricted accessResearch articleFirst published May, 2016

Trend Analysis of FDA Warning Letters Issued to Medical Products About Violations to Current Good Manufacturing Practices (CGMP) Between 2007 and 2014

Liqing Wang, Hang Zheng, Xiaohong Ren [...]

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published December, 2021

Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019

Kimberly G. Wagoner, Allison J. Lazard, E. Alfonso Romero-Sandoval [...]

Cannabis & Cannabinoid Research

Restricted accessOtherFirst published May, 2007

Prescription Drug Advertising and Promotion: Learnings from Recent Food and Drug Administration Warning Letters

Eric B. Benson, Sherman N. Alfors

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2018

Research Misconduct in FDA-Regulated Clinical Trials

Craig A. Garmendia, Neera Bhansali, Purnima Madhivanan

Therapeutic Innovation & Regulatory Science